R&D
Partner Content
3rd mRNA Process Development & Manufacturing Summit
Your Roadmap for mRNA Process Development & Manufacturing with …
19732 items found
News
Home testing devices for sleep apnoea backed for NHS use
Five home-testing devices for obstructive sleep apnoea hypopnoea …
News
Eisai, Biogen start delayed subcutaneous Leqembi filing
Eisai and Biogen have filed a rolling biologics license application …
R&D
News
AbbVie takes option on Gilgamesh CNS drugs in $2bn deal
AbbVie has agreed to pay $65 million on an option deal with start-up …
News
FDA clears Roche self-collection system for HPV screening
The US FDA has approved a human papillomavirus (HPV) self-sampling …
News
ICER raps conduct of Lykos’ psychedelic trial for PTSD
The Institute for Clinical and Economic Review (ICER) typically …
R&D
In vitro gametogenesis: the science has to be right, and it has to be safe
In vitro gametogenesis (IVG) holds much potential for same-sex …
News
Bayer cutbacks start to be felt with 1,500 jobs shed in Q1
Bayer’s first-quarter results update shows that its workforce has …
News
Semaglutide heart benefits may go beyond weight loss
New data suggests that the benefits of Novo Nordisk’s GLP-1 agonist …
Sales & Marketing
Sponsored
12 Questions with Michael Stevinson
Michael Stevinson is Global Agency Head at Caudex, an IPG Health …
News
Cytokinetics prepares to take on BMS’ Camzyos in HCM
Cytokinetics has revealed the results from a phase 3 trial of its …
R&D
Partner Content
Less than three weeks away: Join Global Experts at Transderm...
11-12 November 2024 in London, UK
Sales & Marketing
Enabling site success: Key insights to reducing burden and i...
Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, safely, and in compliance with regulatory standards.
Sales & Marketing
Deep Dive: Commercialisation 2024
In this issue, we unpack Ozempic’s rise to superstar status and the risks associated with its off-label use.
Digital
Sponsored
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
Digital
Access to genomic surveillance: Open science and public heal...
The pandemic served as a catalyst for a revolution in genomic surveillance for tracking pathogens.
Sales & Marketing
Sponsored
Launch Excellence: Moments of Truth
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
R&D
Partner Content
4th mRNA Analytical Development & Quality Control Summit | F...
Excitement for mRNA therapeutics continues, as RNA technologies are awarded the Nobel Prize for the second year running.
Patients
Partner Content
How walking in a patient's shoes adds value to your patient ...
Imagine the difference it would make if everyone in your organisation had firsthand experience of living with one of the conditions you help treat. What insights would you gain?
